Rosiglitazone alone or in combination with tissue plasminogen activator improves ischemic brain injury in an embolic model in rats. (Q45953898)

18 December 2017

title

Rosiglitazone alone or in combination with tissue plasminogen activator improves ischemic brain injury in an embolic model in rats. (English)

1 reference

18 December 2017

1 reference

1 reference

Chen Xu Wang

1

1 reference

18 December 2017

Xiuqing Ding

2

1 reference

18 December 2017

Raza Noor

3

1 reference

18 December 2017

Christina Pegg

4

1 reference

18 December 2017

Chunyan He

5

1 reference

18 December 2017

Ashfaq Shuaib

6

1 reference

18 December 2017

publication date

24 June 2009

1 reference

18 December 2017

Journal of Cerebral Blood Flow & Metabolism

published in

1 reference

18 December 2017

volume

29

1 reference

18 December 2017

issue

10

1 reference

18 December 2017

page(s)

1683-1694

1 reference

18 December 2017

Combination therapy of rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, and NMDA receptor antagonist (MK-801) on experimental embolic stroke in rats

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Blood-brain barrier disruption and matrix metalloproteinase-9 expression during reperfusion injury: mechanical versus embolic focal ischemia in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Effects of rosiglitazone alone and in combination with atorvastatin on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Multiple roles for MMPs and TIMPs in cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Peroxisome proliferator-activated receptor and age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Peroxisome proliferator-activated receptor gamma is expressed in hippocampal neurons and its activation prevents beta-amyloid neurodegeneration: role of Wnt signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Matrix metalloproteinase activation and blood-brain barrier breakdown following thrombolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Extracellular proteolysis in brain injury and inflammation: role for plasminogen activators and matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Recanalization and reperfusion therapies for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Tissue plasminogen activator for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Hyperthermia masks the neuroprotective effects of tissue plaminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Blood-brain barrier tight junction permeability and ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Reduction of ischemic brain injury in rats with normothermic and hyperthermic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Effects of nonpeptide V(1) vasopressin receptor antagonist SR-49059 on infarction volume and recovery of function in a focal embolic stroke model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Interferon gamma induces neurite outgrowth by up-regulation of p35 neuron-specific cyclin-dependent kinase 5 activator via activation of ERK1/2 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Medical significance of peroxisome proliferator-activated receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

An improved version of embolic model of brain ischemic injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Increase of interleukin-1beta mRNA and protein in the spinal cord following experimental traumatic injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Involvement of inflammatory cytokines in central nervous system injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Neuroprotective effects of free radical scavengers in stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Critical role of microvasculature basal lamina in ischemic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

inferred from DOI database lookup

7 January 2021

based on heuristic

Antiinflammatory properties of PPARgamma agonists following ischemia.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

inferred from DOI database lookup

7 January 2021

based on heuristic

Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2009.87

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/JCBFM.2009.87

1 reference

18 December 2017

1 reference

18 December 2017